[1]
“Outcome of Febuxostat treatment in hyperuricemic pre-dialysis chronic kidney disease patients”, J Patan Acad Health Sci, vol. 7, no. 2, pp. 45–52, Aug. 2020, doi: 10.3126/jpahs.v7i2.31111.